Early-Stage Funding of US Biotech Companies




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Early-Stage Funding of US Biotech Companies
Released on: October 01, 2006. © PharmaVentures Ltd
Visitors: You are watching a 1 minute preview.
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    In this month's Business Report we discuss the current climate for the early-stage funding of biotech companies in the US.
  • Summary
  • Transcript
  • Company
In this month's Business Report we discuss the current climate for the early-stage funding of biotech companies in the US. We explore some of the options open to biotech entrepreneurs in order to secure the crucial finances necessary to start a successful business. We assess the trends in early-stage funding awarded by the US National Institutes of Health SBIR and STTR grant programmes and take a closer look at how early-stage funding from Venture Capital sources has changed over the last decade.
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
PharmaVentures Ltd
PharmaVentures is a company that has proven success in deals and alliances.

PharmaVentures offers:


• Over 18 years of healthcare industry experience

• Experience gained from working with in excess of 1000 clients in 38 countries, and conducting more than 450 assignments

• Over 40 specialist advisors, analysts and researchers

• Skills honed in many countries - 80% of its business comes from outside the UK